What’s a woman to do? The latest health care reform is coming in the form of a report from an independent body of clinical specialists who have determined that mammography screening starting at 40 years old has lead to false positives, increased costs and other “risks” that are best handled by changing the time and number of mammograms mandated for women. According to the American College of Radiology, since regular mammography went into widespread use in 1990, the mortality rate from breast cancer has declined by 30 percent.
Medical device and in vitro diagnostics manufacturers are increasingly optimistic about their prospects in 2010, according to new survey of industry executives.
The survey of 1,141 industry managers conducted by the Emergo Group, an Austin, Texas-based consulting firm, found that more than two of three believe the overall business environment will be better for the industry next year compared with 2009. A majority also said they expect to hire additional workers during 2010 and that many were looking to Brazil and Asian countries to help fuel sales gains over the next 12 months.
Twelve of the 32 companies given Excellence in Medical Technologies & Life Sciences awards by Frost & Sullivan have roots in the Bay State.
The global research firm’s annual awards recognize companies that have made major contributions to the medical device, pharmaceutical, biotech and drug discovery and other healthcare fields.
A two-year survey by Crimson Life Sciences found that the average serious error rate — serious enough to cause harm to patients — was 400 percent higher than the serious error rate for industry best practices.
The Brighton-based translation services provider analyzed 21 languages, dozens of labeling audits and more than a million translated words. The high incidence of error suggests that many medical device makers face substantial liability and recall risks from translations of their labeling, company officials claimed.